Literature DB >> 20398015

Opioids in rheumatic diseases.

L J Lang1, M Pierer, C Stein, C Baerwald.   

Abstract

Opioids are the most potent analgesics available and are well established for the treatment of severe acute, surgical, and cancer pain. However, their use to ameliorate chronic noncancer pain (CNCP) is still controversial because of the side effects, such as tolerance, somnolence, confusion, constipation, addiction, withdrawal, and anxiety about disapproval by regulatory bodies. Chronic rheumatic diseases along with low-back pain and arthritis are among the leading causes of CNCP. This article will focus on the role of opioids in chronic rheumatic diseases. Furthermore, the peripheral effects of opioids on pain and inflammation in rheumatic diseases will be outlined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398015     DOI: 10.1111/j.1749-6632.2009.05343.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  Opioid receptors: toward separation of analgesic from undesirable effects.

Authors:  Ping-Yee Law; Patricia H Reggio; Horace H Loh
Journal:  Trends Biochem Sci       Date:  2013-04-16       Impact factor: 13.807

2.  Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus - Michigan Lupus Epidemiology and Surveillance Program, 2014-2015.

Authors:  Emily C Somers; Jiha Lee; Afton L Hassett; Suzanna M Zick; Siobán D Harlow; Charles G Helmick; Kamil E Barbour; Caroline Gordon; Chad M Brummett; Deeba Minhas; Amrita Padda; Lu Wang; W Joseph McCune; Wendy Marder
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-09-27       Impact factor: 17.586

3.  Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions.

Authors:  Katerina S Iwaszkiewicz; Jennifer J Schneider; Susan Hua
Journal:  Front Pharmacol       Date:  2013-10-24       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.